North America represents one of the largest regional markets for DNA bowel cancer screening kits, supported by rising colorectal cancer prevalence, favorable government screening initiatives, and increasing healthcare expenditure. The region is witnessing strong adoption of non-invasive DNA screening technologies as healthcare providers focus on improving early diagnosis and patient outcomes....